Biopharma's Narrowed Patent Protection May Find Relief In Trade Secret Law
A new law intended to better secure trade secrets may also help biopharmaceutical companies safeguard their intellectual property in situations where protection isn't available under the patenting process or the scope of a firm's patent was narrowed because of recent Supreme Court rulings.
You may also be interested in...
US prosecutors have laid out yet another case where very intelligent people made the stupid mistake of thinking they were too smart to get caught.
With the theft of American companies' trade secrets increasingly on the rise – including those belonging to biopharmaceutical firms – lawmakers last week said more needs to be done to ensure there are stronger legal protections in place to secure that commercially valuable information.
With the annual loss to the American economy from intellectual property (IP) theft at about $300 billion – plus millions of jobs lost – the Obama administration last week launched the second stage of its plan of attack against counterfeiters, patent infringers and cybercriminals that are stealing corporate trade and US government secrets.